Related Experiment Videos
Ciprofloxacin in oral treatment of ear infections
Pharmaceutisch Weekblad. Scientific Edition
|February 21, 1986
Abstract:
In a pilot study 29 cases of suppurative otitis were treated with ciprofloxacin. Acceptable clinical results were obtained in case of chronic otitis media without cholesteatoma and in case of otitis externa. Cholesteatoma and mastoid cavity cases gave no satisfactory results. Guidelines are proposed to define the specific indications and place of this drug in suppurative otitis.
Insights
Ciprofloxacin showed good results for chronic otitis media and otitis externa in a pilot study. However, it was not effective for cholesteatoma or mastoid cavity infections, suggesting specific treatment guidelines are needed.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Pharmacology
Background:
- Suppurative otitis is a common condition requiring effective antimicrobial treatment.
- Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic with activity against common pathogens in ear infections.
Purpose of the Study:
- To evaluate the clinical efficacy of ciprofloxacin in treating various forms of suppurative otitis.
- To determine the optimal role and indications for ciprofloxacin in managing suppurative otitis.
Main Methods:
- A pilot study involving 29 patients with suppurative otitis treated with ciprofloxacin.
- Clinical outcomes were assessed for different subtypes of otitis, including chronic otitis media without cholesteatoma, otitis externa, cholesteatoma, and mastoid cavity infections.
Main Results:
- Acceptable clinical results were observed in patients with chronic otitis media without cholesteatoma and otitis externa.
- Unsatisfactory outcomes were reported in cases involving cholesteatoma and mastoid cavity infections.
Conclusions:
- Ciprofloxacin demonstrates efficacy in specific suppurative otitis conditions like chronic otitis media and otitis externa.
- Treatment guidelines are proposed to clarify the appropriate use of ciprofloxacin, excluding its use in cholesteatoma and mastoid cavity infections.